Prevention of excessive exercise-induced adverse effects in rats with Bacillus subtilis BSB3

J Appl Microbiol. 2020 Apr;128(4):1163-1178. doi: 10.1111/jam.14544. Epub 2019 Dec 25.

Abstract

Aims: To characterize efficacy of the Bacillus subtilis BSB3 (BSB3) strain in the prevention of excessive exercise-induced side effects and in maintaining stability of the gut microbiota.

Methods and results: Rats were pretreated by oral gavage with B. subtilis BSB3 (BSB3) or with phosphate-buffered saline (PBS) twice a day for 2 days, and were either exposed forced treadmill running or remained sedentary. Histological analysis of intestine, immunofluorescence staining of tight junction (TJ) proteins, serum lipopolysaccharide and intestinal fatty acid-binding protein assay, culture-based analysis and pyrosequencing for the gut microbiota were performed for each rat. Forced running resulted in a substantial decrease in intestinal villi height and total mucosa thickness, the depletion of Paneth cells, an inhibition of TJ proteins expression. Short-term treatment of rats with BSB3 before running prevented these adverse effects. Culture-based analysis of the gut microbiota revealed significant elevation of pathogenic microorganisms only in treadmill-exercised rats pretreated with PBS. High-throughput 16S rRNA gene sequencing also revealed an increase in pathobionts in this group. Preventive treatment of animals with BSB3 resulted in predominance of beneficial bacteria.

Conclusions: BSB3 prevents excessive exercise-associated complications by beneficial modulation of the gut microbiota.

Significance and impact of the study: Our study shows a new application of beneficial bacteria for prevention the adverse effects of excessive exercise.

Keywords: Bacillus subtilis; I-FABP; LPS; gut microbiota; side effects of excessive exercise; tight junction proteins.

MeSH terms

  • Administration, Oral
  • Animals
  • Bacillus subtilis / physiology*
  • Gastrointestinal Microbiome / drug effects
  • Gastrointestinal Microbiome / genetics
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / microbiology
  • Intestinal Mucosa / pathology
  • Lipopolysaccharides / blood
  • Male
  • Physical Conditioning, Animal / adverse effects*
  • Probiotics* / administration & dosage
  • Probiotics* / pharmacology
  • Rats

Substances

  • Lipopolysaccharides

Grants and funding